$WTRV
White River Energy Corp.

2022 Q3 Form 10-Q Financial Statement

#000149315222022340 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $594.5K $107.00 $530.00
YoY Change
Cost Of Revenue $3.663K $6.710K
YoY Change
Gross Profit -$3.556K -$6.180K
YoY Change
Gross Profit Margin -3323.36% -1166.04%
Selling, General & Admin $1.321M $94.87K $162.6K
YoY Change 30.41% 77.18% 20.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $210.00 $210.00
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $1.321M $128.7K $162.6K
YoY Change 30.41% 46.14% 20.91%
Operating Profit -$11.92M -$132.2K -$168.8K
YoY Change 1076.39% 50.18% 25.51%
Interest Expense $1.918K
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.001M
YoY Change 107.35%
Pretax Income -$11.15M -$132.2K -$164.1K
YoY Change 893.61% -88.35% -154.69%
Income Tax
% Of Pretax Income
Net Earnings -$11.15M -$131.6K -$164.1K
YoY Change 893.61% -88.41% -154.69%
Net Earnings / Revenue -1875.38% -122985.05% -30964.72%
Basic Earnings Per Share -$1.33 -$0.02
Diluted Earnings Per Share -$1.31 -$0.02 -$19.40K
COMMON SHARES
Basic Shares Outstanding 8.400M shares 8.400M shares
Diluted Shares Outstanding 8.400M shares 8.400M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.49K $140.2K
YoY Change -96.37% -93.22%
Cash & Equivalents $579.4K $33.49K $140.2K
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $51.92K $71.76K
YoY Change 2147.62% 1803.45%
Inventory $91.93K $40.90K $107.0K
Prepaid Expenses
Receivables $410.1K $634.5K
Other Receivables
Total Short-Term Assets $1.522M $126.3K $212.0K
YoY Change 98.64% -86.34% -89.78%
LONG-TERM ASSETS
Property, Plant & Equipment $1.431M $1.256K $1.466K
YoY Change 75629.37% -39.9% -36.26%
Goodwill $2.100M
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.76K
YoY Change
Total Long-Term Assets $7.367M $1.460K
YoY Change -36.52%
TOTAL ASSETS
Total Short-Term Assets $1.522M $126.3K $212.0K
Total Long-Term Assets $7.367M $1.460K
Total Assets $8.889M $127.6K $213.5K
YoY Change 1057.09% -86.23% -89.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $344.3K $799.1K
YoY Change 277.28% 1201.47%
Accrued Expenses $289.7K $0.00 $119.6K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $42.67K
YoY Change
Total Short-Term Liabilities $834.0K $69.82K $23.50K
YoY Change 813.83% 47.63% -61.73%
LONG-TERM LIABILITIES
Long-Term Debt $92.70K $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $792.1K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $834.0K $69.82K $23.50K
Total Long-Term Liabilities $792.1K $0.00 $0.00
Total Liabilities $1.626M $69.82K $22.38K
YoY Change 1681.78% 47.63% -63.55%
SHAREHOLDERS EQUITY
Retained Earnings -$29.81M -$4.258M -$16.68M
YoY Change
Common Stock $37.08M $4.318M $592.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.263M $59.49K $191.1K
YoY Change
Total Liabilities & Shareholders Equity $8.889M $127.6K $213.5K
YoY Change 1057.09% -86.23% -89.72%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$11.15M -$131.6K -$164.1K
YoY Change 893.61% -88.41% -154.69%
Depreciation, Depletion And Amortization $210.00 $210.00
YoY Change 0.0% 0.0%
Cash From Operating Activities -$106.7K -$207.6K
YoY Change 6.24% 33.12%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $38.11K
YoY Change -100.0% -77.47%
Cash From Investing Activities $0.00 $38.11K
YoY Change -100.0% -77.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -106.7K -207.6K
Cash From Investing Activities 0.000 38.11K
Cash From Financing Activities 0.000
Net Change In Cash -106.7K $0.00
YoY Change 169.91% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$106.7K -$207.6K
Capital Expenditures $0.00
Free Cash Flow -$106.7K -$207.6K
YoY Change 6.24% 35.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Inventory Net
InventoryNet
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001589361
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2022Q2 us-gaap Goodwill
Goodwill
usd
CY2021Q4 us-gaap Goodwill
Goodwill
usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Gross Profit
GrossProfit
usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
usd
us-gaap Interest Expense
InterestExpense
usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
usd
CY2022Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
usd
CY2021Q2 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
usd
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
BANM Reclassification Of Prepaid Expenses To Inventory
ReclassificationOfPrepaidExpensesToInventory
usd
CY2021Q4 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited Or Expired Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedOrExpiredWeightedAverageExercisePrice
CY2022Q2 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
usd
CY2022Q2 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
usd
CY2020Q4 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
CY2021 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited Or Expired Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedOrExpiredWeightedAverageExercisePrice
CY2021Q4 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
usd
CY2021Q4 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-192060
dei Entity Registrant Name
EntityRegistrantName
Fortium Holdings Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3797537
dei Entity Address Address Line1
EntityAddressAddressLine1
609 West Dickson St.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102 G
dei Entity Address City Or Town
EntityAddressCityOrTown
Fayetteville
dei Entity Address State Or Province
EntityAddressStateOrProvince
AR
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
72701
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
203-5610
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8400000 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33491 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309738 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51916 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20042 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
40901 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
33463 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
126308 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
363243 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1256 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1675 usd
CY2022Q2 us-gaap Assets
Assets
127564 usd
CY2021Q4 us-gaap Assets
Assets
364918 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
69815 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
10842 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
69815 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10842 usd
CY2022Q2 us-gaap Liabilities
Liabilities
69815 usd
CY2021Q4 us-gaap Liabilities
Liabilities
10842 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8400000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8400000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8400000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8400000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
840 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
840 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4316779 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4316779 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4258133 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3963543 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
59486 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
354076 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
-1737 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57749 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
354076 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
127564 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
364918 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
636 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107 usd
us-gaap Cost Of Revenue
CostOfRevenue
10368 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
3663 usd
us-gaap Gross Profit
GrossProfit
-9732 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-3556 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
68000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
68725 usd
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
33793 usd
CY2021Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
34498 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
223243 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
153774 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
94865 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53541 usd
us-gaap Operating Expenses
OperatingExpenses
291243 usd
us-gaap Operating Expenses
OperatingExpenses
222499 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
128658 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
88039 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-300975 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-222499 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-132214 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-88039 usd
us-gaap Interest Expense
InterestExpense
45 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4648 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
173681 usd
CY2021Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
47323 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-786206 usd
CY2021Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1094455 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4648 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-612570 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1047132 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-296327 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-835069 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-132214 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1135171 usd
us-gaap Profit Loss
ProfitLoss
-296327 usd
us-gaap Profit Loss
ProfitLoss
-835069 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-132214 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1135171 usd
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-1737 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-620 usd
us-gaap Net Income Loss
NetIncomeLoss
-294590 usd
us-gaap Net Income Loss
NetIncomeLoss
-835069 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-131594 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1135171 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8400000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7071049 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8400000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7071049 shares
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1714313 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
300102 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2014415 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1135171 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
879244 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
354076 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-164113 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189963 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189963 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-132214 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-132214 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57749 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57749 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-294590 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-835069 usd
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-1737 usd
us-gaap Depreciation
Depreciation
419 usd
us-gaap Depreciation
Depreciation
419 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4648 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
173681 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-786206 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
72775 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
285 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
58973 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-34027 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-19768 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
578632 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-314358 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-256437 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
38111 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
230088 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2513 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
38111 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
227575 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
22500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22500 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-276247 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-51362 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
309738 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63151 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33491 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11789 usd
us-gaap Interest Paid Net
InterestPaidNet
1524 usd
BANM Reclassification Of Prepaid Expenses To Inventory
ReclassificationOfPrepaidExpensesToInventory
40901 usd
CY2021Q4 BANM Percentage Of Gross Sales Revenue On Cash Payment
PercentageOfGrossSalesRevenueOnCashPayment
0.06 pure
CY2021Q4 BANM Annual Royalty Fee
AnnualRoyaltyFee
50000 usd
CY2022Q1 BANM Cash Compensation Based Liability Per Month
CashCompensationBasedLiabilityPerMonth
1000 usd
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Collections of the amounts billed are typically paid by the customers within 30 to 60 days.
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zB5KWVAbqpSk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: justify; text-indent: -9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zv3u6Modjdnb">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, management’s estimate of provisions required for uncollectible accounts receivable, fair value of assets held for sale and assets and liabilities acquired, impaired value of equipment and intangible assets, including goodwill, estimates of discount rates in lease, liabilities to accrue, cost incurred in the satisfaction of performance obligations, permanent and temporary differences related to income taxes and determination of the fair value of stock awards. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Revenue Performance Obligation Description Of Good Or Service
RevenuePerformanceObligationDescriptionOfGoodOrService
contracts with an original expected length of one year or less
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
636 usd
CY2022Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2513 usd
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2513 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1257 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
838 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1256 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1675 usd
us-gaap Depreciation
Depreciation
419 usd
us-gaap Depreciation
Depreciation
419 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8400000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8400000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1400000 shares
CY2021Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
14000 usd
CY2021 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageRemainingContractualTerm
P5Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
1400000 shares
CY2021 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice
-0.01
CY2021 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageRemainingContractualTerm
P5Y
CY2022Q2 us-gaap Inventory Net
InventoryNet
40901 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
45 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.0001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8400000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8400000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
10628 shares
CY2020Q4 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
16.625
CY2021 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm
P1Y8M12D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
1400000 shares
CY2021 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice
0.01
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
10628 shares
CY2021Q4 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
16.625
CY2021 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term1
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm1
P0Y8M12D
CY2021Q4 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
10628 shares
CY2021Q4 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
16.625
CY2021 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm
P0Y8M12D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
10628 shares
CY2021Q4 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
16.625
BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm
P0Y8M12D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
10628 shares
CY2022Q2 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
16.625
BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term1
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm1
P0Y2M12D
CY2022Q2 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
10628 shares
CY2022Q2 BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
16.625
BANM Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm
P0Y2M12D
BANM Outstanding Shares Percentage
OutstandingSharesPercentage
0.1889 pure
us-gaap Gain Loss On Investments
GainLossOnInvestments
4648 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
-918497 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
636 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10368 usd
us-gaap Gross Profit
GrossProfit
-9732 usd
BANM Operating Expenses Excluding Depreciation
OperatingExpensesExcludingDepreciation
290822 usd
us-gaap Depreciation
Depreciation
419 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4648 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-296327 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3663 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-3556 usd
CY2022Q2 BANM Operating Expenses Excluding Depreciation
OperatingExpensesExcludingDepreciation
128448 usd
CY2022Q2 us-gaap Depreciation
Depreciation
210 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-132214 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1256 usd

Files In Submission

Name View Source Status
0001493152-22-022340-index-headers.html Edgar Link pending
0001493152-22-022340-index.html Edgar Link pending
0001493152-22-022340.txt Edgar Link pending
0001493152-22-022340-xbrl.zip Edgar Link pending
banm-20220630.xsd Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex3-1_003.jpg Edgar Link pending
ex3-1_004.jpg Edgar Link pending
ex3-1_005.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
banm-20220630_def.xml Edgar Link unprocessable
banm-20220630_lab.xml Edgar Link unprocessable
banm-20220630_pre.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
form10-q_htm.xml Edgar Link completed
banm-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable